5 drugmakers have recalled metformin products after FDA warning

Since the FDA said in late May that it found unacceptable levels of a caricinogen in metformin — the generic name for a drug commonly used to control blood sugar in Type 2 diabetes patients — five drugmakers have issued recalls of their metformin products. 

Advertisement

The carcinogen, N-nitrosodimethylamine, or NDMA, was originally found by online pharmacy Valisure in early March. 

The five drugmakers that have recalled their metformin products: 

  1. Lupin Pharmaceuticals recalled one lot of its metformin hydrochloride extended-release tablets.
  2. Teva Pharmaceuticals recalled 14 lots of its metformin hydrochloride extended-release tablets, including the 500 mg and 750 mg bottles.
  3. Marksans Pharma Limited recalled one lot of its extended-release metformin tablet.
  4. Amneal Pharmaceuticals recalled all lots of its metformin hydrochloride extended-release tablets.
  5. Apotex recalled all lots of its metformin extended-release tablets. 

More articles on pharmacy:
FDA warns of potential drug interaction with remdesivir
Steroid could reduce COVID-19 deaths: 5 things to know
Walmart buys prescription management tech from CareZone

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

  • A series of recent FDA safety actions, drug recalls, label updates and court rulings across pharmacy carry operational implications for…

Advertisement

Comments are closed.